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Development of the nervous system requires a variety of cellular activities, such
as proliferation, migration, axonal outgrowth and guidance and synapse formation
during the differentiation of neural precursors into mature neurons. Malfunction of
these highly regulated and coordinated events results in various neurological diseases.
The Elongator complex is a multi-subunit complex highly conserved in eukaryotes
whose function has been implicated in the majority of cellular activities underlying
neurodevelopment. These activities include cell motility, actin cytoskeleton organization,
exocytosis, polarized secretion, intracellular trafficking and the maintenance of neural
function. Several studies have associated mutations in Elongator subunits with the
neurological disorders familial dysautonomia (FD), intellectual disability (ID), amyotrophic
lateral sclerosis (ALS) and rolandic epilepsy (RE). Here, we review the various cellular
activities assigned to this complex and discuss the implications for neural development
and disease. Further research in this area has the potential to generate new diagnostic
tools, better prevention strategies and more effective treatment options for a wide variety
of neurological disorders.
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INTRODUCTION
There are over 600 known neurological disorders and we are still far from fully understanding and
finding treatment options for the majority of them. Many neurological disorders are inherited
diseases, arising from defects in the development of the nervous system. Neurodevelopment
is a complex dynamic process regulated by various genetic and environmental factors. The
process is comprised of a series of intricate and coordinated events, required for converting
neural precursor cells into functional neurons. Deregulation of these complex processes leads
to abnormal neurodevelopment and profound neurological dysfunction. Genetic analysis of
various neurodevelopmental disorders, including familial dysautonomia (FD; Anderson et al.,
2001; Slaugenhaupt et al., 2001; Cuajungco et al., 2003), intellectual disability (ID; Najmabadi
et al., 2011; Cohen et al., 2015), amyotrophic lateral sclerosis (ALS; Simpson et al., 2009) and
rolandic epilepsy (RE; Strug et al., 2009), have identified mutations in Elongator complex subunits,
suggesting that this highly evolutionarily conserved complex plays an important role in regulating
neurodevelopment. In eukaryotes, Elongator is associated with diverse cellular activities including
transcriptional elongation (Hawkes et al., 2002; Kim et al., 2002), cytoplasmic kinase signaling
(Holmberg et al., 2002; Close et al., 2006), exocytosis (Rahl et al., 2005), cytoskeletal organization
(Johansen et al., 2008), tubulin acetylation (Creppe et al., 2009) and translation (Huang et al., 2005;
Esberg et al., 2006; Johansson et al., 2008; Bauer et al., 2012). In this review, we discuss the growing
experimental evidence supporting the importance of Elongator in cellular processes known to be
crucially important for neurodevelopment and nervous system function.
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THE ELONGATOR COMPLEX
The Elongator complex consists of six subunits (Elp1–Elp6),
which are organized into two three-subunit sub-complexes:
the core sub-complex Elp123 (Elp1–Elp3), and the accessory
sub-complex Elp456 (Elp4–Elp6; Otero et al., 1999; Li et al.,
2001; Winkler et al., 2001). Each Elongator subunit is structurally
well characterized in yeast (Figure 1A). Elp1 is the largest of
the six subunits and acts as a scaffold for other Elongator
proteins. This subunit harbors several WD40 repeats within
two WD40 propeller domains, and one tetratricopeptide repeat
(TRP) domain that binds specific peptide ligands and mediates
protein–protein interactions (Cortajarena and Regan, 2006).
An additional Elp1 domain has been recently identified: the
C-terminus-localized dimerization domain (Xu et al., 2015;
Figure 1B). Elp2 is the second largest subunit of Elongator
complex with two WD40 propeller domains (Figure 1C; Fellows
et al., 2000). Together with Elp1, Elp2 contributes to the
stability of Elp123 sub-complex and integrates signals from
different factors that regulate Elongator activity. Elp3 functions
as the enzymatic core of Elongator, harboring two domains
essential for Elongator function. These include: the S-adenosyl-
L-methionine (SAM) binding domain required to catalyze a
variety of radical reactions (Paraskevopoulou et al., 2006),
and the histone acetyl-transferase (HAT) domain (Figure 1D;
Wittschieben et al., 1999). Elongator subunits Elp4–6 share a
RecA-like fold (Figure 1E) and assemble into a heterohexameric,
ring-like structure. Glatt et al. (2012) showed that Elp4, 5 and
6 specifically bind to the anti-codon loop of transfer RNAs
(tRNAs) and preserve ATPase activity, likely as means to control
tRNA binding and release. The interaction of Elongator subunits
and complex assembly has been reported by two separate studies,
both proposing that the Elp456 heterohexamer bridges two
peripherally attached Elp123 sub-complexes. These data indicate
that Elongator is a dodecameric complex containing two copies
of each of the six Elongator subunits (Figure 1F; Glatt et al.,
2012; Lin et al., 2012). Elongator subunits are evolutionarily
highly conserved from yeast to humans both in their sequence
and interaction with other subunits. Conserved function across
all species has been clearly demonstrated using a variety of
different cross-species rescue experiments (Li et al., 2005; Chen
et al., 2006, 2009). Deletion of any of the genes encoding the
six subunits confers almost identical biochemical phenotypes in
yeast (Fellows et al., 2000; Winkler et al., 2001; Frohloff et al.,
2003), suggesting that there is a tight functional association
between the proteins comprising the Elongator complex, and
that the functional integrity of Elongator is compromised in the
absence of any of its subunits.
FIGURE 1 | The Elongator complex architecture. (A) Schematic view of Elongator subunits (Elp1–6) and their domain structure highlighted by different colors.
Structural model of: (B) Elp1 harboring two WD40 propeller domains, tetratricopeptide repeat (TRP) and DD domain; (C) Elp2 containing two WD40 propeller
domains; (D) Elp3 with histone acetyl-transferase (HAT) and S-adenosyl-L-methionine (SAM) domain (E) and Elp4, 5 and 6 subunits that share a RecA fold. (F) The
Elongator complex assembly in dodecamer with two Elp123 trimeric sub-complexes peripherally attached to the ring-like hexameric Elp456 sub-complex. Structural
models of Elp1–6 were prepared using program Phyre2 (Kelley and Sternberg, 2009).
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 November 2016 | Volume 9 | Article 115
Kojic and Wainwright Elongator in Neurodevelopment and Disease
The Elongator complex has been reported to orchestrate
multiple functions across diverse organisms. Several loss-of-
function studies have illustrated a key role for this complex in
development by regulating a variety of different cellular activities.
For example, yeast Elp mutants are hypersensitive to high
temperature and osmotic conditions, presenting with defects in
exocytosis, telomeric gene silencing, DNA damage response and
adaption to new growth medium (Wittschieben et al., 1999; Rahl
et al., 2005; Li et al., 2009; Chen et al., 2011). In Arabidopsis
thaliana, mutations in Elp subunits resulted in impaired root
growth (Nelissen et al., 2005), whilst deletion of Elp3 in
Drosophila melanogaster was shown to be lethal at the larval stage
(Walker et al., 2011). Elongator-deficient Caenorhabditis elegans
exhibit defects in neurodevelopment (Solinger et al., 2010). In
mice, a transgenic Elp1 knockout resulted in embryonic lethality
due to failed neurulation and vascular system formation (Chen
et al., 2009). Furthermore, several human neurological disorders
have been linked to a deficiency of the Elongator, which will be
discussed in more detail below.
The substrate specificity of Elongator remains controversial,
and the definite number of roles this complex plays in different
cellular activities is still to be confirmed (also reviewed in
Svejstrup, 2007; Versées et al., 2010; Glatt and Müller, 2013). The
complex was initially identified in yeast as the major component
of RNA polymerase II (RNAPII) holo-enzyme (Otero et al.,
1999; Wittschieben et al., 1999). In vitro studies using the HeLa
cell line further confirmed that Elongator directly interacts
with RNAPII and facilitates transcription in a chromatin- and
acetyl-CoA-dependent manner (Hawkes et al., 2002; Kim et al.,
2002). The Elongator complex has also been reported to play
two other distinct nuclear roles. Knockdown of Elp3 has been
shown to impair paternal DNA demethylation in mouse zygotes,
a process that requires the Elp3 SAM domain (Okada et al.,
2010). The complex was also demonstrated to be involved
in microRNA (miRNA) biogenesis in Arabidopsis, whereby
Elongator is believed to play a role in coupling the transcription
of primary miRNAs and their subsequent processing (Fang
et al., 2015). The majority of Elongator has been found to be
located in the cytoplasm, consistent with the various cellular
processes assigned to this complex that take place in the cytosol.
Two studies have reported that Elongator regulates cytoplasmic
kinase signaling through its interaction with c-Jun N-terminal
kinase (JNK; Holmberg et al., 2002; Close et al., 2006). Holmberg
et al. (2002) showed that Elongator is involved in the assembly of
JNK-MAPK module through the association of Elp1 with JNK,
resulting in JNK activation. Rahl et al. (2005) proposed an active
requirement for the Elongator complex in the establishment and
maintenance of yeast cell polarity, and in exocytosis, through its
interaction with Rab GTPase Sec2p. As suggested by the authors,
Elongator negatively regulates Sec2p-dependent, polarized
secretion through a transcription-independent pathway.
Johansen et al. (2008) proposed a model in which Elp1-assisted
localization of filamin A into membrane ruffles regulates neuron
migration in rats. Another study linked Elongator to the process
of cytoskeletal organization and cell motility by demonstrating
acetylation of α-tubulin by this complex in murine cortical
neurons (Creppe et al., 2009). Although the Elongator complex
has been implicated in the various cellular processes described
here thus far, there is accumulating evidence in the last decade
to indicate that the main role of this complex is to maintain
translational fidelity via regulation of tRNA modifications. In
eukaryotes, U34 in the anticodons of tRNALysUUU, tRNAGluUUC
and tRNAGlnUUG are modified to 5-carbamoyl-methyl-uridine
(ncm5U), 5-methoxy-carbonyl-methyl-uridine (mcm5U), or
5-methoxy-carbonyl-methyl-2-thio-uridine (mcm5s2U). A
number of studies have reported that these modifications
require the Elongator complex (Huang et al., 2005; Esberg
et al., 2006; Johansson et al., 2008; Bauer et al., 2012). The
methyl-group transfer to tRNA U34 by Elongator likely involves
a SAM-mediated mechanism in conjunction with an electron
transfer from a cofactor complex Kti11/Kti13 (Boal et al.,
2011; Kolaj-Robin et al., 2015). However, the precise molecular
mechanism that underlies the tRNA modification by this
complex is yet to be elucidated.
It is still unclear whether Elongator has many distinct
functions in a cell or it regulates one process that leads to different
downstream effects, via altered translation. Interestingly, Esberg
et al. (2006) found that elevated levels of two tRNA species
bypass all the in vivo requirements of Elongator in transcription
and exocytosis. All the phenotypes of Elongator-deficient yeast
cells can be suppressed by overexpression of tRNALysUUU and
tRNAGluUUC (Esberg et al., 2006). A recent study by Bauer
et al. (2012) demonstrated that translation of a large number
of proteins is regulated by Elongator and that cell division is
under translational control of this complex. The most recent
finding in Caenorhabditis elegans shows that Elongator is not
a direct tubulin acetytransferase, but it rather regulates the
expression of α-tubulin acetyltransferase at translational level,
through its elevated AAA codon content and tRNA modification
(Bauer and Hermand, 2012). The other cell activities regulated
by Elongator might also be explained by its tRNA modification
role and codon-dependent regulation of translation, which future
experiments will elucidate.
ROLE OF ELONGATOR IN
NEURODEVELOPMENT
Neural development is a complex process that requires neural
induction, migration, differentiation, axon guidance and synapse
formation. Both cell motility and the actin cytoskeleton play a
central role in regulating how neuronal precursors proliferate
and migrate to different parts of the developing brain. Once
neural precursors have reached their final destination they
undergo the process of differentiation, which involves the
production and extension of axons and dendrites to form
synapses, resulting in the establishment of functional neural
circuits. Synapses are specialized sites of cell–cell contact
where electrical signals trigger the release of neurotransmitters,
which in turn activates postsynaptic receptors (Haucke et al.,
2011). This highly regulated process is based on cytoskeletal
organization, vesicular trafficking and polarized exocytosis.
Here, we review the roles of Elongator during neurodevelopment,
from transcription to translation (Figure 2).
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FIGURE 2 | Multiple roles of the Elongator complex in neurons. The six-subunit Elongator complex is proposed to play multiple roles in cell: a role of
histone-acetyl transferase (HAT) required for transcriptional elongation, it assists c-Jun N-terminal kinase (JNK)-MAPK module assembly, negatively regulates
exocytosis through Sec2p-Sec4 interaction, regulates actin organization via Filamin A, promotes α-tubulin and synaptic proteins acetylation, and modifies transfer
RNA (tRNA) U34. Elongator functions can be associated to cell activities critical for development and maintenance of the nervous system: migration and branching
of neurons, intracellular trafficking and synapse formation, marked with green, purple and black circle in the figure, respectively.
Neurodevelopmental processes are dependent upon a broad
number of factors regulating the expression of hundreds of genes
controlling the terminal differentiation of neurons. The majority
of genes activated during developmental processes are regulated
at the level of transcriptional elongation (Muse et al., 2007).
Elongator has been linked to the transcriptional regulation of
several genes critical to various neurodevelopmental processes.
Studies in human 293T (Han et al., 2007) and HeLa (Li et al.,
2011) cell lines clearly demonstrate a role for the Elongator
complex in the transcriptional elongation of heat shock protein
70 (HSP70), a gene that plays an important role in protecting
of cells from apoptotic stimuli and in the stabilization of
protein structures (Jäättelä et al., 1992; Mosser et al., 1997; Han
et al., 2007). HSPs are developmentally regulated in the nervous
system. HSP70 has been suggested to play an important role in
both developing and adult mammalian brain and its expression
within the nervous system is significantly higher compared
to non-neuronal tissue (Manzerra et al., 1997). HSP70 has a
neuroprotective role (attenuation of toxicity in a variety of
neurodegenerative disease models (Arawaka et al., 2010)), and
plays a role in axonal transport and neuronal signaling (de
Waegh and Brady, 1989; Houenou et al., 1996; Thekkuveettil and
Lakhotia, 1996). Elongator is also required for the activation of
several genes involved in cell migration, such as those coding for
the integrin receptor CD61, tenascin-C, and actin cytoskeleton
modulators (Close et al., 2006). Integrins and tenascin-C are
widely expressed in neuronal extracellular matrix during CNS
development and they are shown to enhance neuronal precursors
proliferation, migration and differentiation (Garcion et al., 2001;
Flanagan et al., 2006). Taken together, these data show that
the Elongator complex is responsible for the transcriptional
regulation of a number of proteins that each plays a crucial role
in various steps of development and maintenance of the nervous
system.
The Elongator complex regulates a broad number of
neurodevelopmental transcription-independent processes.
Elongator activates JNK (Holmberg et al., 2002; Close et al.,
2006), a stress-activated protein kinase that modulates the
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activity of a vast number of pathways. JNK signaling has been
reported to be crucially important for neurodevelopment. JNK
knockout studies in mice revealed its important role in brain
morphogenesis, axonal specification and axon growth and
guidance. In addition, JNK has been shown to govern synapse
and memory formation (reviewed in Coffey, 2014).
Elongator is linked to synaptogenesis based on its role in
vesicular trafficking and exocytosis via interacting with Rab
proteins (Rahl et al., 2005). Rab proteins regulate membrane
trafficking, which include vesicle formation, vesicle movement,
and membrane fusion (Pfeffer, 2001). The yeast Rab protein
Sec4p regulates exocytosis of post-Golgi secretory vesicles
(Salminen and Novick, 1987). Sec2p is an essential protein that
is recruited to sites of exocytosis, it targets the Sec4p activation
event and facilitates polarized exocytosis (Walch-Solimena et al.,
1997). Rahl et al. (2005) propose that the Elongator complex
function in a cytosolic signal transduction pathway to regulate
the localization of Sec2p and thereby the Rab activation event
critical for polarized secretion. Rab proteins play a central role in
neurodevelopment, by regulating the polarized neurite growth,
axonal trafficking, and formation and maintenance of synapses
(specific functions in synaptic vesicle exocytosis, reviewed in Ng
and Tang, 2008).
The Elongator complex has also been shown to regulate
migration of neural precursors through its interaction with
filamin A, whereby Elongator is involved in the recruitment
of filamin A in the membrane ruffles upon cell migration
(Johansen et al., 2008). Elp3 was shown to localize to actin-rich
domains at the edges of spreading HeLa cells (Barton et al.,
2009). Filamin A organizes cortical actin filaments and dynamic
three-dimensional networks in the leading edges of migrating
cells and is essential for regulating the polarity of neocortical
neurons during radial migration through the subventricular zone
(SVZ) and intermediate zone (IZ) of the cerebrum (Nagano
et al., 2004). Loss-of-function mutations in filamin A give rise
to human periventricular heterotopia, a neurodevelopmental
disorder caused by a failure of neurons to migrate to the cortex
(Fox et al., 1998).
Acetylation of α-tubulin by the Elongator complex is
yet another Elongator function that may play role in neural
migration and branching (Creppe et al., 2009). In neurons
the majority of cellular α-tubulin is acetylated. Creppe et al.
(2009) demonstrated that lowering α-tubulin acetylation
levels in microtubules through expression of α-tubulin
K40A (a dominant-negative α-tubulin form that cannot be
acetylated) recapitulated the migratory defects induced by
Elp1/Elp3 silencing. The reduced acetylated α-tubulin levels
seen upon Elongator deficiency in this study, suggest that
this complex does not exclusively regulate cell motility via its
association with filamin A, as migratory defects did not affect
cell transition through neocortical SVZ and IZ or promote
the formation of periventricular nodular heterotopia, nor via
transcriptional elongation of key genes coding for proteins
involved in cell migration, as the identity of these genes was
cell-specific. The relationship between α-tubulin acetylation,
neuron migration and branching is not yet clear but could rely
on intracellular trafficking as α-tubulin acetylation is known to
increase binding of motor proteins that regulate bidirectional
molecular transport in axons and dendrites (Reed et al., 2006).
The growing experimental and clinical evidence suggest that
defective intracellular transport of specific proteins or organelles
might be the hallmarks of several neurodegenerative processes,
such as ALS, Parkinson’s disease, Huntington disease and
Alzheimer’s disease (reviewed in Nguyen et al., 2010).
Elongator regulates neurotransmitter release and synapse
formation, as demonstrated by one study showing that in
Drosophila neurons, this complex is necessary and sufficient
to acetylate Bruchpilot (BRP), an integral component of
the presynaptic density where neurotransmitters are released
(Mi´skiewicz et al., 2011). BRP is a large cytoskeletal-like protein
with its individual strands having their N termini facing the
plasma membrane, contacting Ca2+ channels, and their C
termini extending into cytoplasm capturing synaptic vesicles
(Fouquet et al., 2009; Hallermann et al., 2010). Thus, BRP acts
by concentrating synaptic vesicles at active zones, and facilitating
synaptic transmission by establishing proximity between Ca2+
channels and vesicles to allow efficient transmitter release (Kittel
et al., 2006; Hallermann et al., 2010). Mi´skiewicz et al. (2011)
suggest a model where Elongator is a BRP acetyltransferase
and acetylation of BRP reorganizes its cytoplasmic tentacles,
thereby regulating vesicle capturing by the C-terminal end
of BRP and transport of vesicles at dense bodies. The local
regulation of Elongator may enable single active zones to control
neurotransmitter release and may hold the key to synaptic
transmission regulation. The importance of protein acetylation
in regulation of synapse composition and functionality in
neurons has been demonstrated by recent study (Catarino et al.,
2013). The possible role of Elongator in vesicular trafficking,
exocytosis and synaptic transmission using above mentioned
mechanisms remains to be tested in humans, yet evolutionary
conservation of Elongator implies that it may play a similar
role.
Recent studies have focused largely upon the pivotal role of
Elongator in tRNA modification and these can be related to
neurodevelopment in multiple ways. One recent report shows
that Elongator is indeed linked to the translation of a variety
of cell proteins, including those implicated in cell division
(Bauer and Hermand, 2012). tRNA are more than simple
adaptor molecules and have a surprising range of functions
in the cell, such as tuning translation and protein expression
in a tissue-specific manner and stress signaling, whereby these
functions are all dependent on its modifications (Giegé, 2008;
Thompson and Parker, 2009; Kirchner and Ignatova, 2015).
Klassen et al. (2015) recently showed that the loss of wobble
uridine modifications in the Elongator deficient yeast strain
affects tRNALysUUU function and results in a reduced total
protein level. Moreover, the loss of these modifications in a
subset of tRNAs was shown to lead to ribosome pausing at their
cognate codons in both, yeast and C. elegans (Nedialkova and
Leidel, 2015). Hence, upon Elongator malfunction, the kinetics
of translation is perturbed, leading to the disruption of protein
homeostasis in a cell and aggregate formation, as suggested by
Nedialkova and associates. Neurons are particularly sensitive to
the toxicity of misfolded proteins, hence, this could be the basis
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of neurodegenerative pathologies. In accordance with this, it
can be postulated that Elongator-dependent tRNA modification
regulate critical steps in biosynthesis and homeostasis of
proteins required for the development and survival of specific
neurons.
ELONGATOR DEFECTS IN
NEUROLOGICAL DISORDERS
Mutations in Elongator complex subunits have been linked to
different neuronal diseases (Table 1). Elp1 mutations have been
linked to an autosomal recessive disorder, FD (Anderson et al.,
2001; Slaugenhaupt et al., 2001; Cuajungco et al., 2003). FD
is among the most frequent hereditary sensory and autonomic
neuropathies (Axelrod and Abularrage, 1982; Axelrod, 2002).
The progressive degeneration of the sensory and autonomic
nervous system in FD patients results in the following symptoms:
cardiovascular dysfunction, pain insensitivity, gastrointestinal
dysfunction, scoliosis, vomiting, defective lacrimation, extensive
sweating and postural hypotension (Aguayo et al., 1971;
Axelrod and Abularrage, 1982). Mortality in FD patients
is high, and only 40% of patients survive beyond age 20
(Axelrod, 2004). FD patients have a mutation in the donor
splice site of intron 20 of the Elp1 gene, resulting in
aberrant splicing (Anderson et al., 2001; Slaugenhaupt et al.,
2001; Cuajungco et al., 2003). This mis-splicing results in
tissue-specific exon skipping and consequently reduced levels of
the Elp1 full-length protein. The FD mutation is incompletely
penetrant, since the full length Elp1 is still synthesized albeit
at lower levels in other cell types, whereas, in the central
and peripheral nervous system only the truncated product
is made (Slaugenhaupt et al., 2001; Cuajungco et al., 2003).
This Elp1 truncated form cannot be detected in patients due
to its degradation by the nonsense-mediated decay pathway
(Cuajungco et al., 2003; Slaugenhaupt et al., 2004). Hence,
Elp1 levels are very low in neuronal tissue from FD patients
and unchanged in lymphoblasts for instance (Slaugenhaupt
et al., 2001; Cuajungco et al., 2003). Heterozygous carriers
also show reduced Elp1 expression but do not develop FD,
suggesting the existence of an Elp1 tissue-specific threshold for
the appropriate nervous system development and functioning.
Experiments in HeLa, neuronal derived Elp1 RNAi cells and FD
fibroblasts, showed that the Elp1-deficient cells exhibit defects
in cell motility in vitro (Close et al., 2006). More recently,
one group demonstrated that the cerebrum and fibroblasts
from FD patients have reduced levels of mcm5s2 modifications
at tRNA U34 (Karlsborn et al., 2014), which was further
confirmed by Yoshida et al. (2015). This suggests that reduced
levels of Elp1 due to aberrant splicing result in inefficient
translation in FD, once again supporting the hypothesis that the
predominant role of Elongator is the regulation of the rate of
translation.
ID is a disorder characterized by incomplete mental
development, which results in limitations in both intellectual
functioning and adaptive behavior (Schalock et al., 2010). A
large-scale sequencing study identified missense mutations in
the Elp2 gene to be associated with ID or related neurological
disabilities. Homozygous mutations in the Elp2 gene were found
in two families, each with three children suffering from moderate
or severe IDs (Najmabadi et al., 2011). Cohen et al. (2015)
recently reported on one more family with two brothers being
affected by severe ID, spastic diplegia and self-injury. In both
brothers, sequencing analysis found Elp2 missense mutations to
be linked with the inheritance of this disorder. One of the two
Elp2 gene mutations identified in this family was shown to have
the same amino acid position as the recessive missense mutation
in one of the two previously reported families (Najmabadi et al.,
2011). The mechanism of this neurodevelopmental dysfunction
may be related to the compromised function of the Elongator
complex, due to the presence of a dysfunctional Elp2 subunit
that normally acts as a signal-transducing platform. Thus,
Elp2 is likely to be a novel gene that has an important
role in the development of recessive cognitive disorders, such
as ID.
ALS, commonly called motor neuron disease, has been
associated to allelic variants of Elp3 gene (Simpson et al.,
2009). ALS is a neurodegenerative disease characterized by
progressive muscle weakness and atrophy due to degeneration
of motor neurones in the primary motor cortex, corticospinal
tracts, brainstem and spinal cord (Rowland and Shneider,
2001). Within 3 years of onset of the disease, respiratory
muscle weakness generally results in death. The causative
molecular pathway underlying ALS remains unknown and
it is considered to be a complex disease caused by interplay
between multiple mechanisms (Rowland and Shneider, 2001).
Two independent studies performed by Simpson et al. (2009): a
microsatellite-based genetic association study of ALS in humans
and a mutagenesis screen in Drosophila melanogaster, identified
allelic variants of Elp3 gene as crucial for axonal biology. In the
genetic association study, Elp3 allelic variants were associated
with ALS in three different populations. A mutagenesis screen in
Drosophila identified Elp3 mutations that conferred abnormal
photoreceptor axonal targeting and neurodegeneration. In
addition to this, Elp3 knockdown in zebrafish via morpholino
technology resulted in dose-dependent shortening and abnormal
branching of motor neurons. Therefore, understanding
TABLE 1 | Elongator defects in neurological disorders.
Neurological disorder Affected Elp Mutation Reference
Familial dysautonomia Elpl Mutation in the donor splice site of intron 20 Anderson et al. (2001), Slaugenhaupt et al. (2001) and Cuajungco et al. (2003)
Intellectual disability Elp2 Missense mutations Najmabadi et al. (2011) and Cohen et al. (2015)
Amyotrophic lateral sclerosis Elp3 Association with specific haplotype Simpson et al. (2009)
Rolandic epilepsy Elp4 Non-coding mutations Strug et al. (2009)
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Elongator function is a promising route whereby we might
gain insights into the mechanism of motor neuron degeneration
in ALS.
Elp4 mutations have been linked to RE, the most common
human epilepsy, with onset at 7–10 years of age (Gomez and
Klass, 1983). A neurodevelopmental disorder with epileptic focus
typically located in the lower motor and/or somatosensory cortex
(rolandic area; Koutroumanidis, 2007), RE is characterized
by centro-temporal spikes (CTS) on an electroencephalogram.
The common form of RE appears to have complex genetic
inheritance, where the genetic contribution to the disease is yet
to be elucidated. A recent study suggests that Elp4 mutations
are associated with CTS in RE families (Strug et al., 2009).
A genome-wide association study in RE was conducted and
fine mapping evidence pointed to the association of CTS with
SNP markers in Elp4 in both, discovery and replication data
sets. Beside RE, there are other neurodevelopmental disorders
associated with the CTS trait, such as speech disorder (Echenne
et al., 1992) developmental coordination disorder (Scabar et al.,
2006) and attention deficit-hyperactivity disorder (Holtmann
et al., 2003) that could be also linked to Elp4, as in the case
of RE. Strug et al. (2009) hypothesized that a non-coding
mutation in Elp4 gene impairs Elongator-mediated interaction
of genes important for brain development, which leads to the
susceptibility to seizures in neurodevelopmental disorders.
Given that Elongator has been shown to be involved
in a variety of neurodevelopmental processes, this complex
might be associated with a broad range of neurological
disorders. Neurodegenerative diseases are mostly accompanied
by transcriptional dysfunction, leading to neuronal death and in
many of these cases, chromatin acetylation status is impaired by a
mechanism related to the loss of HAT activity (Selvi et al., 2010).
On the other hand, the Elongator association with neurological
disorders could be through its tRNA modification role. Growing
experimental evidence supports the link between tRNAs and
neurological disorders (Kirchner and Ignatova, 2015). Several
reports have associated ID and mutations in genes that encode
for tRNA modification enzymes (Torres et al., 2014). A defect in
Elongator complex-dependent tRNA modification could perturb
translation in two different ways, by reducing the protein
synthesis due to general slow-down of translation of lysine
rich proteins that are found predominantly in the ribosomal
machinery, or by leading to translational inaccuracy and protein
misfolding. Neurons are known to be vulnerable to misfolded
proteins, and the prion-like spread of pathogenic misfolded
proteins probably holds a key as a general mechanism underlying
neurodegeneration (Raj et al., 2012; Zhou et al., 2012). Warren
et al. (2013) proposed the term ‘‘molecular nexopathy’’ to link
accumulation of toxic protein aggregates with neural network
disintegration, and argued that this can be a new paradigm of
neurodegenerative diseases. Elongator-dependent regulation of
translation could be an important factor contributing to this new
paradigm.
CONCLUDING REMARKS
The Elongator complex is a dodecamer composed of six subunits
(Elp1–6) with two Elp123 trimeric sub-complexes peripherally
attached to the ring-like hexameric Elp456 sub-complex (Glatt
et al., 2012). It is a highly conserved complex among eukaryotes
and its function is dependent on the integrity of all its subunits.
Although a large number of cellular functions have been
attributed to this complex, the predominant role of Elongator
is in regulating tRNA modification. Yet a large amount of
data exists to support a possibility that Elongator acts as a
transcriptional regulator. Future high-resolution structural and
functional studies aimed to identifying Elongator interactors,
regulators, the molecular mechanism underlying its activity and
substrate specificity will shed light on the true nature of this
multi-subunit complex.
Elongator activity has been linked to a host of cellular
processes crucial for neurodevelopment, including cytoskeletal
organization, neuritogenesis, axon growth, axonal transport,
neuronal signaling and cell motility. A role for Elongator in a
number of distinct neurological disorders is emerging yet. The
mechanism by which the perturbation of the complex leads to the
specific neuropathogenic effects is yet to be defined. Once this is
elucidated, exploration of methods to complement for Elongator
dysfunction offers an approach to developing effective therapies
for a variety of neurological disorders.
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